INR 34.3
(7.39%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 13.4 Million INR | 4.88% |
2022 | 12.78 Million INR | 22.33% |
2021 | 10.44 Million INR | -50.38% |
2020 | 21.05 Million INR | 12.67% |
2019 | 18.68 Million INR | 12.83% |
2018 | 16.56 Million INR | 78.16% |
2017 | 9.29 Million INR | -17.68% |
2016 | 11.29 Million INR | -17.24% |
2015 | 13.64 Million INR | 30.59% |
2014 | 10.45 Million INR | 62.68% |
2013 | 6.42 Million INR | -78.37% |
2012 | 29.69 Million INR | 5.0% |
2011 | 28.28 Million INR | 21.43% |
2010 | 23.28 Million INR | 302.94% |
2009 | 5.77 Million INR | 234.74% |
2008 | 1.72 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 13.4 Million INR | 4.88% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 13.65 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 13.4 Million INR | 0.0% |
2022 Q4 | 12.78 Million INR | 0.0% |
2022 FY | 12.78 Million INR | 22.33% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 10.64 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 12.85 Million INR | 0.0% |
2021 FY | 10.44 Million INR | -50.38% |
2021 Q4 | 10.44 Million INR | 0.0% |
2020 FY | 21.05 Million INR | 12.67% |
2020 Q4 | 21.05 Million INR | 0.0% |
2020 Q2 | 13.73 Million INR | 0.0% |
2019 FY | 18.68 Million INR | 12.83% |
2019 Q2 | 11.54 Million INR | 0.0% |
2019 Q4 | 18.68 Million INR | 0.0% |
2018 FY | 16.56 Million INR | 78.16% |
2018 Q2 | 9.62 Million INR | 0.0% |
2018 Q4 | 16.56 Million INR | 0.0% |
2017 Q2 | 10.05 Million INR | 0.0% |
2017 Q4 | 9.29 Million INR | 0.0% |
2017 FY | 9.29 Million INR | -17.68% |
2016 FY | 11.29 Million INR | -17.24% |
2016 Q4 | 11.29 Million INR | 0.0% |
2016 Q2 | 16.06 Million INR | 0.0% |
2015 FY | 13.64 Million INR | 30.59% |
2015 Q2 | 11.21 Million INR | 0.0% |
2015 Q4 | 13.64 Million INR | 0.0% |
2014 Q4 | 10.45 Million INR | 0.0% |
2014 Q2 | 11.99 Million INR | 0.0% |
2014 FY | 10.45 Million INR | 62.68% |
2013 Q4 | 6.42 Million INR | -3.0% |
2013 Q3 | 6.62 Million INR | 30.71% |
2013 FY | 6.42 Million INR | -78.37% |
2013 Q2 | 5.06 Million INR | 0.0% |
2012 Q3 | 27.53 Million INR | 0.0% |
2012 Q4 | 29.69 Million INR | 7.83% |
2012 FY | 29.69 Million INR | 5.0% |
2011 FY | 28.28 Million INR | 21.43% |
2011 Q4 | 28.28 Million INR | 0.0% |
2010 FY | 23.28 Million INR | 302.94% |
2009 FY | 5.77 Million INR | 234.74% |
2008 FY | 1.72 Million INR | 0.0% |
2008 Q4 | 1.72 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
DECIPHER LABS LIMITED | 117.72 Million INR | 88.613% |
Gujarat Themis Biosyn Limited | 197.37 Million INR | 93.208% |
Ishita Drugs and Industries Limited | 8.87 Million INR | -51.093% |
MedPlus Health Services Limited | 14.27 Billion INR | 99.906% |
ANG Lifesciences India Limited | 1.66 Billion INR | 99.193% |
Add-Shop E-Retail Limited | 159.2 Million INR | 91.58% |
Bacil Pharma Limited | 1.12 Million INR | -1087.334% |
BDH Industries Limited | 312.53 Million INR | 95.711% |
Beryl Drugs Limited | 85.63 Million INR | 84.347% |
Cian Healthcare Limited | 1.03 Billion INR | 98.704% |
Chemo Pharma Laboratories Limited | 2.12 Million INR | -529.934% |
Concord Drugs Limited | 249.88 Million INR | 94.636% |
Deccan Health Care Limited | 111.33 Million INR | 87.96% |
Gujarat Terce Laboratories Limited | 161.67 Million INR | 91.709% |
Hindustan Bio Sciences Limited | 25.7 Million INR | 47.843% |
Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 93.35% |
KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 98.655% |
Kwality Pharmaceuticals Limited | 1.71 Billion INR | 99.219% |
Makers Laboratories Limited | 569.18 Million INR | 97.645% |
Medi-Caps Limited | 63.01 Million INR | 78.728% |
Panchsheel Organics Limited | 340.2 Million INR | 96.06% |
Parmax Pharma Limited | 117.56 Million INR | 88.598% |
Parnax Lab Limited | 1.17 Billion INR | 98.855% |
Patidar Buildcon Limited | 25.57 Million INR | 47.579% |
Phaarmasia Limited | 211.49 Million INR | 93.662% |
Vikram Thermo (India) Limited | 291.47 Million INR | 95.401% |
Sanjivani Paranteral Limited. | 155.06 Million INR | 91.355% |
SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -4383.278% |
Smruthi Organics Limited | 485.72 Million INR | 97.24% |
Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | 68.062% |
SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 99.218% |
Trident Lifeline Limited | 331.26 Million INR | 95.953% |
Transchem Limited | 6.72 Million INR | -99.479% |
Trinity League India Limited | 876 Thousand INR | -1430.251% |
Tyche Industries Limited | 101.64 Million INR | 86.811% |
Vista Pharmaceuticals Limited | 175.16 Million INR | 92.347% |
Vivanza Biosciences Limited | 148.63 Million INR | 90.981% |
PRAVEG LIMITED | 767.53 Million INR | 98.253% |
Sastasundar Ventures Limited | 1.5 Billion INR | 99.107% |
Sunil Healthcare Limited | 902.83 Million INR | 98.515% |
Syschem (India) Limited | 1.07 Billion INR | 98.748% |
Zenith Healthcare Limited | 24.03 Million INR | 44.227% |
Zenlabs Ethica Limited | 301.35 Million INR | 95.552% |
Mercury Laboratories Limited | 171.18 Million INR | 92.169% |
SHELTER PHARMA LIMITED | 20.99 Million INR | 36.136% |
Vasundhara Rasayans Limited | 53.64 Million INR | 75.013% |
Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 98.665% |
Roopa Industries Limited | 493.08 Million INR | 97.281% |
PANJON LTD. | 25.38 Million INR | 47.189% |
Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 93.569% |
TIAAN CONSUMER LIMITED | 14.97 Million INR | 10.508% |
Anuh Pharma Limited | 1.54 Billion INR | 99.132% |
Crestchem Limited | 23.94 Million INR | 44.022% |
Sandu Pharmaceuticals Limited | 118.22 Million INR | 88.661% |
Fredun Pharmaceuticals Limited | 1.86 Billion INR | 99.28% |
Trimurthi Limited | 101.36 Thousand INR | -13125.138% |
Shukra Pharmaceuticals Limited | 201.97 Million INR | 93.363% |
Norris Medicines Limited | 278.17 Million INR | 95.181% |
Veerhealth Care Limited | 62.78 Million INR | 78.648% |
Lactose (India) Limited | 536.39 Million INR | 97.501% |
OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 98.391% |
Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 98.815% |
Gennex Laboratories Limited | 535.21 Million INR | 97.495% |
Denis Chem Lab Limited | 289.82 Million INR | 95.375% |
Colinz Laboratories Limited | 24.1 Million INR | 44.389% |
Godavari Drugs Limited | 957.86 Million INR | 98.601% |
Zenotech Laboratories Limited | 156.64 Million INR | 91.443% |
Shree Ganesh Remedies Limited | 488.36 Million INR | 97.255% |
Bharat Parenterals Limited | 2.65 Billion INR | 99.495% |
Coral Laboratories Limited | 281.83 Million INR | 95.244% |
Evoq Remedies Limited | 116.23 Million INR | 88.467% |
Kerala Ayurveda Limited | 1.05 Billion INR | 98.733% |
KOBO BIOTECH LIMITED | 2.04 Billion INR | 99.344% |
Natural Capsules Limited | 1.47 Billion INR | 99.093% |
Auro Laboratories Limited | 433.09 Million INR | 96.905% |